Olezarsen for treating familial chylomicronaemia syndrome [ID6585]

  • In development
  • GID-TA11678
  • Expected publication date: 
To appraise the clinical and cost effectiveness of Olezarsen within its marketing authorisation for treating familial chylomicronaemia syndrome ID6585